Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
Clinical trial NCT02681263 · UNKNOWN
Trial details
- NCT number
- NCT02681263
- Sponsor
- University Hospital, Grenoble
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.